These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30155446)

  • 1. The Deconstructed Granuloma: A Complex High-Throughput Drug Screening Platform for the Discovery of Host-Directed Therapeutics Against Tuberculosis.
    Huang L; Kushner NL; Theriault ME; Pisu D; Tan S; McNamara CW; Petrassi HM; Russell DG; Brown AC
    Front Cell Infect Microbiol; 2018; 8():275. PubMed ID: 30155446
    [No Abstract]   [Full Text] [Related]  

  • 2. A high-throughput cidality screen for Mycobacterium tuberculosis.
    Kaur P; Ghosh A; Krishnamurthy RV; Bhattacharjee DG; Achar V; Datta S; Narayanan S; Anbarasu A; Ramaiah S
    PLoS One; 2015; 10(2):e0117577. PubMed ID: 25693161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated surrogate model for screening of drugs against Mycobacterium tuberculosis.
    Gupta A; Bhakta S
    J Antimicrob Chemother; 2012 Jun; 67(6):1380-91. PubMed ID: 22398649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening.
    Grzelak EM; Choules MP; Gao W; Cai G; Wan B; Wang Y; McAlpine JB; Cheng J; Jin Y; Lee H; Suh JW; Pauli GF; Franzblau SG; Jaki BU; Cho S
    J Antibiot (Tokyo); 2019 Oct; 72(10):719-728. PubMed ID: 31292530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hit Generation in TB Drug Discovery: From Genome to Granuloma.
    Yuan T; Sampson NS
    Chem Rev; 2018 Feb; 118(4):1887-1916. PubMed ID: 29384369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Discovery Platform Targeting M. tuberculosis with Human Embryonic Stem Cell-Derived Macrophages.
    Han HW; Seo HH; Jo HY; Han HJ; Falcão VCA; Delorme V; Heo J; Shum D; Choi JH; Lee JM; Lee SH; Heo HR; Hong SH; Park MH; Thimmulappa RK; Kim JH
    Stem Cell Reports; 2019 Dec; 13(6):980-991. PubMed ID: 31680058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosis.
    Silva-Miranda M; Ekaza E; Breiman A; Asehnoune K; Barros-Aguirre D; Pethe K; Ewann F; Brodin P; Ballell-Pages L; Altare F
    Antimicrob Agents Chemother; 2015 Jan; 59(1):693-7. PubMed ID: 25348525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium tuberculosis High-Throughput Screening.
    White EL; Tower NA; Rasmussen L
    Methods Mol Biol; 2016; 1439():181-95. PubMed ID: 27316996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in host-based screening for compounds with intracellular anti-mycobacterial activity.
    Subhash N; Sundaramurthy V
    Cell Microbiol; 2021 Jul; 23(7):e13337. PubMed ID: 33813790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening approaches and therapeutic targets: The two driving wheels of tuberculosis drug discovery.
    Perveen S; Sharma R
    Biochem Pharmacol; 2022 Mar; 197():114906. PubMed ID: 34990594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel drug target strategies against Mycobacterium tuberculosis.
    Murphy DJ; Brown JR
    Curr Opin Microbiol; 2008 Oct; 11(5):422-7. PubMed ID: 18801459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.
    Manjunatha UH; Smith PW
    Bioorg Med Chem; 2015 Aug; 23(16):5087-97. PubMed ID: 25577708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model.
    Guirado E; Mbawuike U; Keiser TL; Arcos J; Azad AK; Wang SH; Schlesinger LS
    mBio; 2015 Feb; 6(1):e02537-14. PubMed ID: 25691598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high content screening assay for identifying inhibitors against active and dormant state intracellular Mycobacterium tuberculosis.
    Yeware A; Agrawal S; Sarkar D
    J Microbiol Methods; 2019 Sep; 164():105687. PubMed ID: 31415793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection.
    Marimani M; Ahmad A; Duse A
    Tuberculosis (Edinb); 2018 Dec; 113():200-214. PubMed ID: 30514504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.
    Ozeki Y; Igarashi M; Doe M; Tamaru A; Kinoshita N; Ogura Y; Iwamoto T; Sawa R; Umekita M; Enany S; Nishiuchi Y; Osada-Oka M; Hayashi T; Niki M; Tateishi Y; Hatano M; Matsumoto S
    PLoS One; 2015; 10(11):e0141658. PubMed ID: 26571296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
    Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
    J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.